IDEAS home Printed from
MyIDEAS: Log in (now much improved!) to follow this author

Afschin Gandjour

This is information that was supplied by Afschin Gandjour in registering through RePEc. If you are Afschin Gandjour , you may change this information at the RePEc Author Service. Or if you are not registered and would like to be listed as well, register at the RePEc Author Service. When you register or update your RePEc registration, you may identify the papers and articles you have authored.

Personal Details

First Name:Afschin
Middle Name:
Last Name:Gandjour
RePEc Short-ID:pga659
[This author has chosen not to make the email address public]
Frankfurt, Germany

: 069 154008-0

Sonnemannstraße 9-11, 60314 Frankfurt am Main
RePEc:edi:hfbfide (more details at EDIRC)
in new window
  1. Afschin Gandjour, 2012. "Caregivers’ Quality of Life and Economic Evaluations," PharmacoEconomics, Springer, vol. 30(9), pages 857-858, September.
  2. Afschin Gandjour, 2012. "Presenting Germany’s drug pricing rule as a cost-per-QALY rule," Health Care Management Science, Springer, vol. 15(2), pages 103-107, June.
  3. Afschin Gandjour, 2011. "Prioritizing Comparative Effectiveness Research," PharmacoEconomics, Springer, vol. 29(7), pages 555-561, July.
  4. Dirk Mueller & Afschin Gandjour, 2011. "Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis," Applied Health Economics and Health Policy, Springer, vol. 9(4), pages 259-273, July.
  5. Gandjour, Afschin & Chernyak, Nadja, 2011. "A new prize system for drug innovation," Health Policy, Elsevier, vol. 102(2), pages 170-177.
  6. Gandjour, Afschin & Gafni, Amiram, 2010. "The additive utility assumption of the QALY model revisited," Journal of Health Economics, Elsevier, vol. 29(2), pages 325-328, March.
  7. Afschin Gandjour, 2010. "A model to predict the cost-effectiveness of disease management programs," Health Economics, John Wiley & Sons, Ltd., vol. 19(6), pages 697-715.
  8. Afschin Gandjour, 2010. "Investment in quality improvement: how to maximize the return," Health Economics, John Wiley & Sons, Ltd., vol. 19(1), pages 31-42.
  9. Afschin Gandjour, 2009. "Aging diseases - do they prevent preventive health care from saving costs?," Health Economics, John Wiley & Sons, Ltd., vol. 18(3), pages 355-362.
  10. Kyra Kneis & Afschin Gandjour, 2009. "Economic evaluation of Sinfrontal®in the treatment of acute maxillary sinusitis in adults," Applied Health Economics and Health Policy, Springer, vol. 7(3), pages 181-191, September.
  11. Dirk Mueller & Eva Weyler & Afschin Gandjour, 2008. "Cost Effectiveness of the German Screen-and-Treat Strategy for Postmenopausal Osteoporosis," PharmacoEconomics, Springer, vol. 26(6), pages 513-536, June.
  12. Afschin Gandjour, 2008. "Incorporating feelings related to the uncertainty about future health in utility measurement," Health Economics, John Wiley & Sons, Ltd., vol. 17(10), pages 1207-1213.
  13. Afschin Gandjour, 2008. "Mutual dependency between capabilities and functionings in Amartya Sen’s capability approach," Social Choice and Welfare, Springer;The Society for Social Choice and Welfare, vol. 31(2), pages 345-350, August.
  14. Gandjour, Afschin & Stock, Stephanie, 2007. "A national hypertension treatment program in Germany and its estimated impact on costs, life expectancy, and cost-effectiveness," Health Policy, Elsevier, vol. 83(2-3), pages 257-267, October.
  15. Afschin Gandjour, 2006. "Consumption costs and earnings during added years of life - a reply to Nyman," Health Economics, John Wiley & Sons, Ltd., vol. 15(3), pages 315-317.
  16. Afschin Gandjour & Eva-Julia Weyler, 2006. "Cost-effectiveness of referrals to high-volume hospitals: An analysis based on a probabilistic Markov model for hip fracture surgeries," Health Care Management Science, Springer, vol. 9(4), pages 359-369, November.
  17. Gandjour, Afschin & Lauterbach, Karl Wilhelm, 2005. "Does prevention save costs?: Considering deferral of the expensive last year of life," Journal of Health Economics, Elsevier, vol. 24(4), pages 715-724, July.
    RePEc:wkh:phecon:v:29:y:2011:i:2:p:97-105 is not listed on IDEAS
    RePEc:wkh:phecon:v:16:y:1999:i:2:p:141-152 is not listed on IDEAS
    RePEc:wkh:aheahp:v:4:y:2005:i:1:p:1-4 is not listed on IDEAS
    RePEc:wkh:aheahp:v:9:y:2011:i:2:p:65-71 is not listed on IDEAS
    RePEc:wkh:phecon:v:27:y:2009:i:5:p:431-432 is not listed on IDEAS
    RePEc:wkh:phecon:v:26:y:2008:i:11:p:895-898 is not listed on IDEAS
    RePEc:wkh:aheahp:v:6:y:2008:i:2-3:p:113-135 is not listed on IDEAS
    RePEc:wkh:phecon:v:26:y:2008:i:10:p:891-892 is not listed on IDEAS

Most cited item

Most downloaded item (past 12 months)

Access and download statistics for all items

For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Afschin Gandjour should log into the RePEc Author Service

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.